Peter K. Honig's most recent trade in Karyopharm Therapeutics Inc was a trade of 34,000 Nonstatutory Stock Option (right to buy) done . Disclosure was reported to the exchange on May 24, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | Peter K. Honig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Karyopharm Therapeutics Inc | Peter K. Honig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 10,995 | 10,995 | - | - | Nonstatutory Stock Option (right to buy) |